Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,972.00
Bid: 1,971.00
Ask: 1,972.00
Change: -28.00 (-1.40%)
Spread: 1.00 (0.051%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Pharma deals lift stocks as FTSE 100 nears 6,700

Tue, 22nd Apr 2014 11:36

- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation- GSK announces massive three-part deal with NovartistechMARK 2,741.04 +2.28%FTSE 100 6,691.88 +1.01%FTSE 250 16,103.19 +1.23%Heightened M&A activity in the pharmaceutical sector gave UK markets a boost on Tuesday, sending London's FTSE 100 towards the psychological level of 6,700.AstraZeneca was rising strongly on speculation that Pfizer could make a takeover approach for the company, in a transaction valued in the region of £60bn, representing the biggest deal ever in the industry's history and the largest foreign takeover of a UK business on record.Meanwhile, GlaxoSmithKline (GSK) jumped after announcing a massive three-part deal with Swiss pharmaceuticals peer Novartis, which will see shareholders receive a £4bn capital return. US companies Eli Lilly and Allergan were also making headlines on the back of M&A speculation today, lifting sentiment across the sector.Investors returned to their desks in a positive mood following the four-day Bank Holiday weekend, sending the FTSE 100 1% higher to 6,692 by midday. London's benchmark index has not closed above this level since April 4th, when it finished the session at 6,695.55. It has not consolidated above the key 6,700 level since March 7th."Traders have stumbled back to their desks this morning after an indulgent long weekend of chocolate consumption. Whilst the economic day has gotten off to a slow start, there has been bid activity that has seen the premier index rise to its highest level in around two weeks," said Chris Beauchamp, Market Analyst at IG.There is no major economic data scheduled for today's session, with the exception of some housing data from the States later in the day. US stock futures were pointing to a subdued start on Wall Street later on.Astra, GSK lead pharma stocks highAstraZeneca was trading 7% higher after The Sunday Times said Pfizer made a tentative $100bn approach for its British-Swedish rival. While AstraZeneca reportedly rejected the informal offer, Analyst Andrew Baum from Citigroup said he expected Pfizer to "push aggressively ahead with a second approach".Investors at GSK celebrated the company's announcement of a new Consumer Healthcare business to be created with Novartis, along with the exchange of certain assets in a major three-part transaction. The proposed deal "accelerates our strategy to generate sustainable, broadly sourced sales growth and improve long-term earnings", said GSK's Chief Executive Sir Andrew Witty.Others in the sector including Shire, Hikma, BTG and NMC Health were also making decent gains, along with pharmaceutical and biotech investment trust Worldwide Healthcare.Heading the other way were resource stocks with Anglo American, Rio Tinto, Randgold, Glencore Xstrata and Fresnillo moving in the red.Even Polymetal was lower despite the Russian precious metals producer saying it had made a "strong start to the year" with 34% growth in production. Sales, however, lagged output during the period due to seasonal factors.FTSE 250-listed telecoms provider Colt dropped 12% after saying margin pressures chipped away at quarterly earnings. The company warned that full-year operating profit before restructuring charges is expected to range between 5% and 10% below current consensus estimates.FTSE 100 - RisersAstraZeneca (AZN) 4,049.50p +7.09%GlaxoSmithKline (GSK) 1,644.50p +5.48%Shire Plc (SHP) 3,054.00p +4.41%Hargreaves Lansdown (HL.) 1,242.00p +3.24%Sports Direct International (SPD) 823.00p +3.00%Melrose Industries (MRO) 288.70p +2.45%Experian (EXPN) 1,107.00p +2.41%Royal Mail (RMG) 521.00p +2.36%Sage Group (SGE) 411.90p +2.21%ITV (ITV) 190.30p +2.20%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 4,662.00p -1.19%Anglo American (AAL) 1,529.00p -1.16%Standard Chartered (STAN) 1,317.00p -0.64%Fresnillo (FRES) 864.00p -0.46%Rio Tinto (RIO) 3,275.50p -0.40%Babcock International Group (BAB) 1,212.00p -0.33%Royal Dutch Shell 'B' (RDSB) 2,385.50p -0.31%Barratt Developments (BDEV) 373.80p -0.27%Glencore Xstrata (GLEN) 313.60p -0.18%Tullow Oil (TLW) 866.50p -0.12%FTSE 250 - RisersWorldwide Healthcare Trust (WWH) 1,292.00p +6.34%JD Sports Fashion (JD.) 1,819.00p +4.84%Heritage Oil (HOIL) 268.70p +4.72%Hikma Pharmaceuticals (HIK) 1,562.00p +4.41%Ocado Group (OCDO) 365.40p +4.34%Xaar (XAR) 893.00p +4.32%BTG (BTG) 551.00p +4.06%Spectris (SXS) 2,363.00p +4.01%Intermediate Capital Group (ICP) 447.50p +3.64%Phoenix Group Holdings (DI) (PHNX) 662.50p +3.52%FTSE 250 - FallersCOLT Group SA (COLT) 127.40p -11.96%Diploma (DPLM) 656.00p -1.87%Centamin (DI) (CEY) 52.85p -1.67%Croda International (CRDA) 2,548.00p -1.09%QinetiQ Group (QQ.) 219.20p -1.08%PayPoint (PAY) 1,169.00p -0.93%African Barrick Gold (ABG) 256.70p -0.93%Polymetal International (POLY) 608.50p -0.81%Kazakhmys (KAZ) 232.30p -0.73%esure Group (ESUR) 252.30p -0.67%BC
More News
12 Apr 2023 07:52

LONDON BRIEFING: Anglo American's De Beers shines; Unite bookings up

(Alliance News) - Stocks in London were called flat on Wednesday, with the focus for the day on a US inflation reading in the afternoon, before the release of central bank meeting minutes later.

Read more
12 Apr 2023 07:18

Hikma appoints Riad Mishlawi as CEO

(Sharecast News) - Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.

Read more
6 Apr 2023 09:20

LONDON BROKER RATINGS: Goldman raises Spirent to 'neutral' from 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
16 Mar 2023 15:50

UK dividends calendar - next 7 days

Friday 17 March 
JPMorgan Claverhouse Investment Trust PLCdividend payment date
Knights Group Holdings PLCdividend payment date
NCC Group PLCdividend payment date
Pershing Square Holdings Ltddividend payment date
Ruffer Investment Co Ltddividend payment date
Witan Investment Trust PLCdividend payment date
Monday 20 March 
Aquila Energy Efficiency Trust PLCdividend payment date
Essentra PLCspecial ex-dividend payment date  
Shaftesbury Capital PLCdividend payment date
Tuesday 21 March 
abrdn Asia Focus PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
Unilever PLCdividend payment date
Wednesday 22 March 
abrdn Equity Income Trust PLCdividend payment date
Thursday 23 March 
BlackRock Energy & Resources Income Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
Close Brothers Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Craneware PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Glanbia PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Hipgnosis Songs Fund Ltdex-dividend payment date
Jersey Electricity PLCdividend payment date
Nichols PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Prudential PLCex-dividend payment date
Schroders PLCex-dividend payment date
Securities Trust of Scotland PLCex-dividend payment date
Volution Group PLCex-dividend payment date
XP Power Ltdex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
13 Mar 2023 09:40

LONDON BROKER RATINGS: JPMorgan cuts BAT; raises Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Mar 2023 09:15

LONDON BROKER RATINGS: Liberum cuts National Express to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.